- Home
- PRAX vs ASM Comparison
PRAX vs ASM Comparison
Compare PRAX & ASM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- ASM
- Stock Information
- Founded
- PRAX 2015
- ASM 1968
- Country
- PRAX United States
- ASM Canada
- Employees
- PRAX N/A
- ASM 253
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- ASM Metal Mining
- Sector
- PRAX Health Care
- ASM Basic Materials
- Exchange
- PRAX Nasdaq
- ASM Nasdaq
- Market Cap
- PRAX 599.7M
- ASM 538.8M
- IPO Year
- PRAX 2020
- ASM N/A
- Fundamental
- Price
- PRAX $42.34
- ASM $3.47
- Analyst Decision
- PRAX Strong Buy
- ASM Strong Buy
- Analyst Count
- PRAX 11
- ASM 2
- Target Price
- PRAX $114.73
- ASM $2.30
- AVG Volume (30 Days)
- PRAX 279.7K
- ASM 5.6M
- Earning Date
- PRAX 08-12-2025
- ASM 08-12-2025
- Dividend Yield
- PRAX N/A
- ASM N/A
- EPS Growth
- PRAX N/A
- ASM 715.13
- EPS
- PRAX N/A
- ASM 0.10
- Revenue
- PRAX $8,122,000.00
- ASM $72,621,000.00
- Revenue This Year
- PRAX N/A
- ASM $22.93
- Revenue Next Year
- PRAX $6,358.50
- ASM $25.22
- P/E Ratio
- PRAX N/A
- ASM $38.84
- Revenue Growth
- PRAX 270.02
- ASM 56.32
- 52 Week Low
- PRAX $26.70
- ASM $0.83
- 52 Week High
- PRAX $91.83
- ASM $3.81
- Technical
- Relative Strength Index (RSI)
- PRAX 54.36
- ASM 60.86
- Support Level
- PRAX $41.64
- ASM $3.39
- Resistance Level
- PRAX $44.99
- ASM $3.81
- Average True Range (ATR)
- PRAX 2.55
- ASM 0.20
- MACD
- PRAX -0.11
- ASM -0.04
- Stochastic Oscillator
- PRAX 51.07
- ASM 40.52
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.